Neoplasms: all 9,617 studies
Page 60 of 97. Open to participants first (2,509), then studies with results posted, then the rest; newest registration first within each.
- Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53TerminatedNCT03975387Phase 1
- Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 AntibodyStatus unknownNCT03975036Phase 2/3
- Blastic Plasmacytoid Dendritic Cell Neoplasm in Korean Population.CompletedNCT03974971
- Epidemiology of Pituitary Tumours: Prevalence of Associated NeoplasiaStatus unknownNCT03973450
- Movement and Fitness Trackers in Determining Performance StatusTerminatedNCT03971266Not applicable
- An In-vitro Real-time System Based on Tissue Smears to Identify Malignancy During Hysteroscopic ProcedureStatus unknownNCT03971032Not applicable
- A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid TumorsSuspendedNCT03970382Phase 1
- Perioperative Ostomy Self-Management Telehealth for Cancer Patients and Family CaregiversCompletedNCT03970070Phase 2
- Evaluation of the Incidence of Cancer in the Follow-up of Women With 3 Consecutive Embryonic Demises Before 10 Weeks or 1 Fetal Death, According to Their Thrombophilia Status, With a Special Focus on Women With an Obstetric Antiphospholipid Symdrome (oAPS)CompletedNCT03969498
- Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast CancerCompletedNCT03969121Phase 3
- Efficacy of Olaparib in Advanced Cancers Occurring in Patients With Germline Mutations or Somatic Tumor Mutations in Homologous Recombination GenesActive, not recruitingNCT03967938Phase 2
- Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid TumorsActive, not recruitingNCT03967223Phase 2
- A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid TumorsCompletedNCT03965845Phase 1/2
- A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) and BI 754111 or BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab)CompletedNCT03964233Phase 1
- Impact of Sick Peer Relation on Adaptation to Disease and on Treatment of Cancer-suffering Adolescents & Young AdultsCompletedNCT03964116Not applicable
- Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCTTerminatedNCT03963024Phase 1
- Cohort of Patients Over 70 Years of Age With Cancer and / or Hematological MalignancyStatus unknownNCT03960593
- Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With CancerCompletedNCT03956459Not applicable
- CD19-Synthetic T Cell Antigen Receptor(STAR)-T in B-cell Malignancies PatientsCompletedNCT03953599Phase 1
- A Study of a Personalized Cancer Vaccine Targeting Shared NeoantigensCompletedNCT03953235Phase 1/2
- CD19-CAR-T in B-cell Malignancies PatientsCompletedNCT03952923Phase 1
- The STEPP Study: Sensors To Evaluate Physical PerformanceCompletedNCT03952767Not applicable
- Patient-Centered Assessment of Symptoms and OutcomesCompletedNCT03952624
- Durvalumab and Olaparib in Metastatic or Recurrent Endometrial CancerStatus unknownNCT03951415Phase 2
- Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management StudyStatus unknownNCT03951324
- Study of FCN-437c in Patients With Advanced Solid TumorsCompletedNCT03951116Phase 1
- Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer PatientsCompletedNCT03951090Not applicable
- Database for Data Collection in the Context of an Enhanced Recovery After Surgery Program in Oncology SurgeryStatus unknownNCT03950011
- A Study of MEDI1191 in Sequential and Concurrent Combination With Durvalumab in Subjects With Advanced Solid TumorsCompletedNCT03946800Phase 1
- Expressive Helping for Chinese-Speaking Cancer Patients and SurvivorsCompletedNCT03945734Not applicable
- Study of ASP8374, an Immune Checkpoint Inhibitor, in Japanese Patients With Advanced Solid TumorsCompletedNCT03945253Phase 1
- Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical TrialsTerminatedNCT03943082Not applicable
- Cell-free Tumor DNA in Head and Neck Cancer PatientsStatus unknownNCT03942380Not applicable
- Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional TherapyCompletedNCT03941262Phase 1
- Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid TumorsStatus unknownNCT03940820Phase 1/2
- Dexmedetomidine Addition to Morphine in Patients With Metastatic CancerCompletedNCT03936205Phase 2/3
- A Study to Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid TumorsCompletedNCT03934359Phase 1
- Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid TumorsStatus unknownNCT03932565Phase 1
- Clinical Research of ROBO1 Specific BiCAR-NK/T Cells on Patients With Malignant TumorStatus unknownNCT03931720Phase 1/2
- A Study of OKI-179 in Patients With Solid TumorsCompletedNCT03931681Phase 1
- 18F-Fluciclovine PET to Distinguish Tumor Progression From Radiation NecrosisCompletedNCT03930173Early Phase 1
- Anlotinib in Advanced Solid Tumors With FGFR AlterationStatus unknownNCT03929965Not applicable
- A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerCompletedNCT03929666Phase 2
- Personalized Therapy of Molecular Tumor Board Participation With the Guidance of Next Generation SequencingStatus unknownNCT03929653
- Analysis of Chemical Pattern Exhaled by Different Neoplasms Through Chemoresistive Nanostructured SensorsStatus unknownNCT03929185
- Follow-up of Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy by Electronic Patient Reported Outcomes-toolCompletedNCT03928938Not applicable
- Advanced Refractory Solid Tumors With TP53 Mutations Register StudyStatus unknownNCT03927599
- Trend Analysis of the Service of Pediatric Palliative CareStatus unknownNCT03925831
- Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and LymphomasWithdrawnNCT03925428Phase 1
- Psycho-social Determinant for Sport Practised During CancerCompletedNCT03919149
- A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001)CompletedNCT03918278Phase 1
- Evaluate Safety, Tolerability and Pharmacokinetics of HLX22 in Patients With Advanced Solid Tumors Overexpressing HER2CompletedNCT03916094Phase 1
- Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid TumorsActive, not recruitingNCT03915678Phase 2
- Expanded Access Neoantigen Vaccine in Solid TumorsNo longer availableNCT03914872
- A Trial of Tisotumab Vedotin in Japanese Subjects With Advanced Solid MalignanciesCompletedNCT03913741Phase 1/2
- Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid TumorsCompletedNCT03911557Phase 2
- Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBCStatus unknownNCT03910712Phase 2
- A Study of INCMGA00012, INCB001158, and the Combination in Japanese Participants With Advanced Solid TumorsCompletedNCT03910530Phase 1
- Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral NeuropathyCompletedNCT03909464
- MPN Podcast Pilot StudyCompletedNCT03907774
- The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility PhaseCompletedNCT03907436Not applicable
- HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid MalignanciesWithdrawnNCT03906643Phase 1
- The Effects of High-flow Nasal Oxygen on Oxygenation During Rigid Bronchoscopy Under General Anesthesia in Pediatric PatientsStatus unknownNCT03905733
- Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid TumorsWithdrawnNCT03905538Early Phase 1
- Cancer Survivors Acute Exercise Response 1Status unknownNCT03903848Not applicable
- : A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid TumorsCompletedNCT03903705Phase 1/2
- Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological MalignancyCompletedNCT03903185Phase 1/2
- Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of XNW7201 in Subjects With Advanced Solid TumorsCompletedNCT03901950Phase 1
- Study of TQB2450 Combined With Anlotinib in Patients With Advanced Solid TumorsStatus unknownNCT03897283Phase 1
- Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary TumorsCompletedNCT03895970Phase 2
- Parenting Skills Intervention in Improving Medication Adherence in Pediatric Cancer PatientsCompletedNCT03895918Not applicable
- Phase 1 Trial of the LSD1 Inhibitor SP-2577 (Seclidemstat) in Patients With Advanced Solid TumorsCompletedNCT03895684Phase 1
- A Study of F0002-ADC in Chinese Patients With Refractory or Recurrent CD30+ Hematologic Malignancies.CompletedNCT03894150Phase 1
- A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsActive, not recruitingNCT03893955Phase 1
- Ultrasound-assisted Thoracic Epidural Catheter InsertionCompletedNCT03890640Not applicable
- Airway Segmented Stent Modified With 3D Printing for Malignant Stricture Involving Carina and Distal BronchiStatus unknownNCT03890575Not applicable
- The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric CancerStatus unknownNCT03889626Phase 3
- A Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid TumorsCompletedNCT03889275Phase 1
- Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune SystemTerminatedNCT03889093Not applicable
- VPA Expanded UCB Transplantation for Treatment of Patients With Hematological MalignanciesCompletedNCT03885947Phase 1
- The Clinical Significance of Ovarian Function Detection and Protection in Fertility Preservation Surgery for Ovarian MalignancyStatus unknownNCT03882190Not applicable
- Clinical and Functional Variables in OncologyCompletedNCT03879096Not applicable
- Trial of Surufatinib Combined With JS001 in the Treatment of Advanced Solid TumorsStatus unknownNCT03879057Phase 1
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer SurvivorsActive, not recruitingNCT03878407
- Study of IBI318 in Participants With Advanced MalignanciesCompletedNCT03875157Phase 1
- Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.CompletedNCT03874897Phase 1
- The Belgian Molecular Profiling Program of Metastatic Cancer for Clinical Decision and Treatment AssignmentStatus unknownNCT03873103
- [177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion UptakeCompletedNCT03872778Phase 1/2
- Radiomics Multifactorial Biomarker for Pulmonary NodulesCompletedNCT03872362
- Study of HPN536 in Patients With Advanced Cancers Associated With Mesothelin ExpressionCompletedNCT03872206Phase 1
- A Study of SHR-1702 Alone or With Camrelizumab in Participants With Advanced Relapsed/Refractory Solid TumorsTerminatedNCT03871855Phase 1
- Peptide-based Immunization for Colon- and and Pancreas-carcinomaCompletedNCT03871790
- Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive ExpressionCompletedNCT03870399Phase 2
- DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2Status unknownNCT03870113Phase 1
- Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.Active, not recruitingNCT03869892Phase 3
- First in Human Dose Escalation Study of YL-13027 in Subjects With Advanced Stage Solid TumorsStatus unknownNCT03869632Phase 1
- Endoscopic Full Thickness Resection Versus Standard Therapy of the Colorectal NeoplasiaStatus unknownNCT03868605Not applicable
- Rapid On Site Evaluation of Pleural Touch Preparations in Diagnosing Malignant Pleural Effusion in Patients Undergoing PleuroscopyCompletedNCT03868579Not applicable
- Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid CancersWithdrawnNCT03868423Phase 2